Clinical Trial Update: A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial of apatinib in patients with advanced non-squamous non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Non-Small-Cell Lung Cancer | Phase 2 | Status: COMPLETED